Acme Universal Safezone 9 Ltd IPO
- Price band
- ₹65 to ₹71
- Issue size
- ₹35.93 Cr
- Issue price
- ₹71
- Lot size
- 1,600 shares
- Min. investment
- ₹2,27,200
- Listing return
- +42.25%
3,200 shares
Listed ₹101
Opens
28 Sep 2026
Closes
30 Sep 2026
Allotment
1 Oct 2026
Listing
6 Oct 2026
Subscription
About the company
Acme Universal Safezone 9 Limited makes and supplies industrial safety footwear sold under the 'ACME' brand. It sits in the personal protective equipment (PPE) space and serves sectors such as construction, oil and gas, mining, heavy engineering, automotive, pharmaceuticals, chemicals, foundries and power generation.
The range spans 15 product lines built on EVA-rubber, nitrile rubber and PVC soles, offering protection from impact, compression, penetration, electrical shock, heat, fire, chemicals and slipping. Customised designs are also developed for buyers, with ICad3D technology used for design and visualisation. Manufacturing runs across four plants in Madhya Pradesh and Uttar Pradesh, and goods reach customers via institutional sales, distributors, dealers and digital/e-commerce channels, backed by warehousing at more than 40 locations in India. Exports go to markets including the UAE, Bahrain, Saudi Arabia, Nigeria, Israel, the Netherlands, Hong Kong and Mauritius.
Objective of IPO proceeds
| Particulars | Estimated amount (₹ Cr.) |
|---|---|
| Funding capital expenditure requirements for the installation of solar power plant | 3.62 |
| Funding capital expenditure requirements towards installation of additional machinery | 8.95 |
| Funding incremental working capital requirements of the company | 8 |
| Funding inorganic growth through unidentified acquisitions and other strategic initiatives | — |
| General corporate purposes. | — |
Key performance indicators (KPIs)
for the year ended March 31, 2026
- ROCE5.54%
- EBITDA Margin7.36%
- PAT Margin2.84%
- Return on Net Worth (RoNW)11.75%
Debt-to-equity Ratio
1.1
Price to Book Value
1.89
Net Asset Value (NAV) per Equity Share
37.6
EPS (Pre IPO)
4.17
View table
| KPI | Value (for the year ended March 31, 2026) |
|---|---|
| ROCE (%) | 5.54 |
| EBITDA Margin (%) | 7.36 |
| PAT Margin (%) | 2.84 |
| Debt-to-equity Ratio | 1.1 |
| Return on Net Worth (RoNW) (%) | 11.75 |
| Price to Book Value | 1.89 |
| Net Asset Value (NAV) per Equity Share (₹) | 37.6 |
| EPS (Pre IPO) (₹) | 4.17 |
Financials
₹ croreRevenue
205.9
Total Assets
146.72
Profit
5.86
View table
| Line | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 178.94 | 187.35 | 205.9 |
| Total Assets | 119.07 | 133.7 | 146.72 |
| Profit | 7.56 | 0.8 | 5.86 |
Book running lead managers & registrar
| Book running lead managers | Expert Global Consultants Private Limited |
|---|---|
| Registrar to the issue | Maashitla Securities Private Limited |
| Market maker to the issue | JSK Securities and Services Private Limited |
Acme Universal Safezone 9 IPO contact details
| Company name | Acme Universal Safezone 9 Limited |
|---|---|
| Registered office | Near Twelve Shops Girwai Naka, A. B. Road, Gwalior, Madhya Pradesh, India, 474001 |
| Phone | +91 93008 70326 |
| compliance@acmeuniversal9.com | |
| Website | www.acmeuniversal9.com |
Acme Universal Safezone 9 IPO registrar contact details
| Company name | Maashitla Securities Private Limited |
|---|---|
| Phone | +91 11 47581432 |
| ipo@maashitla.com | |
| Website | www.maashitla.com |
Thesis
- 1
Production is handled end to end at four plants in Madhya Pradesh and Uttar Pradesh, covering leather cutting, upper assembly, lasting, sole injection, finishing and packaging, with warehousing support for stock, order consolidation and dispatch.
- 2
The company says it uses German Desma PU direct injection machines and Orisol automated stitching equipment, alongside digital process monitoring tied to SAP S/4 HANA, triple density manufacturing, Phylon rubber processing and Surge Sense technology.
- 3
Its 15 product lines, using EVA-rubber, nitrile rubber and PVC soles, guard against impact, penetration, electrical shock, heat, fire, chemicals and slipping, and meet standards such as IS 15298, EN ISO 20345 and ASTM F2413 where applicable.
- 4
A dedicated R&D unit and testing lab support material choice, structural design, development and compliance checks, with batch-wise records kept for tensile strength, flex resistance, compression, electrical properties and sole bond strength.
- 5
Sales flow through direct institutional accounts, regional distributors and dealers, and digital/e-commerce routes, reaching sectors from construction and mining to pharmaceuticals and heavy engineering, while exports cover the UAE, Bahrain, Saudi Arabia, Nigeria, Israel, the Netherlands, Hong Kong, Cameroon and Mauritius.
- 6
Long-term rate contracts and annual supply agreements with corporate buyers are managed by dedicated sales representatives handling negotiations, pricing, delivery schedules and after-sales coordination.
- 7
Revenue from operations has grown steadily, from Rs 178.94 crore in FY24 to Rs 187.35 crore in FY25 and Rs 205.90 crore in FY26.
Application details
Individual investor
₹65 - ₹71 · from ₹2,00,000 onwards.
1,600sharesMin 3,200
Figures come from the company filing. This is not a recommendation.